Selected article for: "rank correlation and statistical analysis"

Author: Willer, K.; Fingerle, A.; Noichl, W.; De Marco, F.; Frank, M.; Urban, T.; Schick, R.; Gustschin, A.; Gleich, B.; Herzen, J.; Koehler, T.; Yaroshenko, A.; Pralow, T.; Zimmermann, G.; Renger, B.; Sauter, A.; Pfeiffer, D.; Makowski, M.; Rummeny, E.; Grenier, P.; Pfeiffer, F.
Title: X-ray Dark-Field Chest Imaging can Detect and Quantify Emphysema in COPD Patients
  • Cord-id: 2dxrnp7c
  • Document date: 2021_1_15
  • ID: 2dxrnp7c
    Snippet: Background Diseases of the respiratory system are leading global causes of chronic morbidity and mortality. While advanced medical imaging technologies of today deliver detailed diagnostic information, a low-dose, fast, and inexpensive option for early detection and/or follow-ups is still lacking. Here, we report on the first human application of a novel modality, namely X-ray dark-field chest imaging, which might fill this gap. Enabling the assessment of microstructural changes in lung parenchy
    Document: Background Diseases of the respiratory system are leading global causes of chronic morbidity and mortality. While advanced medical imaging technologies of today deliver detailed diagnostic information, a low-dose, fast, and inexpensive option for early detection and/or follow-ups is still lacking. Here, we report on the first human application of a novel modality, namely X-ray dark-field chest imaging, which might fill this gap. Enabling the assessment of microstructural changes in lung parenchyma, this technique presents a more sensitive alternative to conventional chest X-rays, and yet requires only a fraction of the dose applied in computed tomography (CT). Methods For this first clinical evaluation, we have built a novel dark-field chest X-ray system, which is also capable of simultaneously acquiring a conventional thorax radiograph (7 seconds, 0.035 mSv effective dose). Representing a major medical condition, we selected chronic obstructive pulmonary disease as study subject to obtain a first impression of potential diagnostic benefits relevant to humans. For a collective of 77 patients with different disease stages, X-ray dark-field- and CT-images were acquired and visually assessed by 5 readers. In addition, pulmonary function tests were performed for every patient. The individual data sets were evaluated in a statistical work-up using correlation testing, rank-based analysis of variance, and pair-wise post-hoc comparison. Findings Compared to CT-based parameters (quantitative emphysema: rho=-0.27, p=0.0893 and visual emphysema: rho=-0.45, p=0.0028), the dark-field signal (rho=0.62, p<0.0001) yields a stronger correlation with diffusion capacity in the evaluated collective. Emphysema assessment based on dark-field chest X-ray features yields consistent conclusions with findings from visual CT image interpretation and shows improved diagnostic performance in comparison to conventional clinical tests characterizing emphysema. Interpretation X-ray dark-field chest imaging allows the diagnosis of pulmonary emphysema as it provides relevant information representing the structural condition of lung parenchyma. Significant diagnostic benefits are also expected for other lung disorders. Funding European Research Council, Royal Philips, Karlsruhe Nano Micro Facility.

    Search related documents:
    Co phrase search for related documents
    • longitudinal study and low frequency: 1
    • longitudinal study and low middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • longitudinal study and low sensitivity: 1
    • longitudinal study and lung cancer: 1, 2, 3, 4, 5, 6, 7
    • longitudinal study and lung capacity: 1, 2, 3, 4
    • longitudinal study and lung diffusion capacity: 1
    • longitudinal study and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • longitudinal study and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • longitudinal study and lung parenchyma: 1
    • longitudinal study and lung tissue: 1
    • longitudinal study and lung volume: 1, 2
    • low frequency and lung cancer: 1, 2
    • low frequency and lung capacity: 1
    • low frequency and lung disease: 1, 2, 3, 4
    • low frequency and lung function: 1, 2, 3
    • low frequency and lung function decline: 1
    • low frequency and lung health: 1
    • low frequency and lung pathology: 1
    • low frequency and lung tissue: 1, 2